Mexiprim Solution 50 mg/ml, 2 ml Ampoules, 10 ct
Antioxidant & Neuroprotective Injection with Ethylmethylhydroxypyridine Succinate
Product Overview
Mexiprim Solution for Injection contains ethylmethylhydroxypyridine succinate, an antioxidant and membrane-protective agent commonly used in neurological and vascular therapy protocols. The injectable formulation is administered intravenously (IV) or intramuscularly (IM) and is traditionally used in complex therapy for cerebrovascular disorders, anxiety-related conditions, cognitive impairment, and oxidative stress-related conditions.
Key Benefits
Supports antioxidant protection
Helps support cerebral circulation and metabolism
Commonly used in neurological support protocols
Supports resistance to oxidative stress and hypoxia
May support cognitive and stress-response functions
Active Ingredient
Ethylmethylhydroxypyridine succinate — 50 mg/ml
Each 2 ml ampoule contains 100 mg of active ingredient.
Verified Ingredients
Ethylmethylhydroxypyridine succinate
Water for injection
How It Works
Ethylmethylhydroxypyridine succinate:
Provides antioxidant and membrane-protective activity
Helps reduce oxidative stress and lipid peroxidation
Supports cerebral metabolism and microcirculation
May help improve resistance to hypoxia and stress conditions
Indications (Typical Use)
Acute cerebrovascular disorders (as part of combination therapy)
Anxiety and neurosis-like conditions
Vegetative dysfunction syndromes
Mild cognitive impairment
Alcohol withdrawal support
Supportive neurological and vascular therapy
How to Use
Route: Intravenous (IV) or Intramuscular (IM) injection
Typical dosing depends on indication and medical supervision. Common adult dosing ranges include:
- 50–100 mg 1–3 times daily initially
- Gradual dose increase depending on response
- Maximum daily dose: 800 mg
For IV infusion, the solution is commonly diluted in sodium chloride solution and administered slowly.
Treatment duration varies depending on the condition being treated.
Pack Size
10 ampoules × 2 ml
Important Features
50 mg/ml injectable formulation
IV and IM administration
Antioxidant and neuroprotective support
Ampoule format for clinical use
Precautions
Avoid if:
Severe liver impairment
Severe kidney impairment
Hypersensitivity to any ingredient
Not recommended during:
Pregnancy
Breastfeeding
Childhood due to insufficient safety data
Possible side effects:
Dry mouth
Nausea
Drowsiness
Allergic reactions
Use under healthcare supervision.
Disclaimer
This product should be used only according to healthcare professional guidance and local prescribing regulations.
Original: $69.99
-65%$69.99
$24.50Mexiprim Solution 50 mg/ml, 2 ml Ampoules, 10 ct
Antioxidant & Neuroprotective Injection with Ethylmethylhydroxypyridine Succinate
Product Overview
Mexiprim Solution for Injection contains ethylmethylhydroxypyridine succinate, an antioxidant and membrane-protective agent commonly used in neurological and vascular therapy protocols. The injectable formulation is administered intravenously (IV) or intramuscularly (IM) and is traditionally used in complex therapy for cerebrovascular disorders, anxiety-related conditions, cognitive impairment, and oxidative stress-related conditions.
Key Benefits
Supports antioxidant protection
Helps support cerebral circulation and metabolism
Commonly used in neurological support protocols
Supports resistance to oxidative stress and hypoxia
May support cognitive and stress-response functions
Active Ingredient
Ethylmethylhydroxypyridine succinate — 50 mg/ml
Each 2 ml ampoule contains 100 mg of active ingredient.
Verified Ingredients
Ethylmethylhydroxypyridine succinate
Water for injection
How It Works
Ethylmethylhydroxypyridine succinate:
Provides antioxidant and membrane-protective activity
Helps reduce oxidative stress and lipid peroxidation
Supports cerebral metabolism and microcirculation
May help improve resistance to hypoxia and stress conditions
Indications (Typical Use)
Acute cerebrovascular disorders (as part of combination therapy)
Anxiety and neurosis-like conditions
Vegetative dysfunction syndromes
Mild cognitive impairment
Alcohol withdrawal support
Supportive neurological and vascular therapy
How to Use
Route: Intravenous (IV) or Intramuscular (IM) injection
Typical dosing depends on indication and medical supervision. Common adult dosing ranges include:
- 50–100 mg 1–3 times daily initially
- Gradual dose increase depending on response
- Maximum daily dose: 800 mg
For IV infusion, the solution is commonly diluted in sodium chloride solution and administered slowly.
Treatment duration varies depending on the condition being treated.
Pack Size
10 ampoules × 2 ml
Important Features
50 mg/ml injectable formulation
IV and IM administration
Antioxidant and neuroprotective support
Ampoule format for clinical use
Precautions
Avoid if:
Severe liver impairment
Severe kidney impairment
Hypersensitivity to any ingredient
Not recommended during:
Pregnancy
Breastfeeding
Childhood due to insufficient safety data
Possible side effects:
Dry mouth
Nausea
Drowsiness
Allergic reactions
Use under healthcare supervision.
Disclaimer
This product should be used only according to healthcare professional guidance and local prescribing regulations.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Antioxidant & Neuroprotective Injection with Ethylmethylhydroxypyridine Succinate
Product Overview
Mexiprim Solution for Injection contains ethylmethylhydroxypyridine succinate, an antioxidant and membrane-protective agent commonly used in neurological and vascular therapy protocols. The injectable formulation is administered intravenously (IV) or intramuscularly (IM) and is traditionally used in complex therapy for cerebrovascular disorders, anxiety-related conditions, cognitive impairment, and oxidative stress-related conditions.
Key Benefits
Supports antioxidant protection
Helps support cerebral circulation and metabolism
Commonly used in neurological support protocols
Supports resistance to oxidative stress and hypoxia
May support cognitive and stress-response functions
Active Ingredient
Ethylmethylhydroxypyridine succinate — 50 mg/ml
Each 2 ml ampoule contains 100 mg of active ingredient.
Verified Ingredients
Ethylmethylhydroxypyridine succinate
Water for injection
How It Works
Ethylmethylhydroxypyridine succinate:
Provides antioxidant and membrane-protective activity
Helps reduce oxidative stress and lipid peroxidation
Supports cerebral metabolism and microcirculation
May help improve resistance to hypoxia and stress conditions
Indications (Typical Use)
Acute cerebrovascular disorders (as part of combination therapy)
Anxiety and neurosis-like conditions
Vegetative dysfunction syndromes
Mild cognitive impairment
Alcohol withdrawal support
Supportive neurological and vascular therapy
How to Use
Route: Intravenous (IV) or Intramuscular (IM) injection
Typical dosing depends on indication and medical supervision. Common adult dosing ranges include:
- 50–100 mg 1–3 times daily initially
- Gradual dose increase depending on response
- Maximum daily dose: 800 mg
For IV infusion, the solution is commonly diluted in sodium chloride solution and administered slowly.
Treatment duration varies depending on the condition being treated.
Pack Size
10 ampoules × 2 ml
Important Features
50 mg/ml injectable formulation
IV and IM administration
Antioxidant and neuroprotective support
Ampoule format for clinical use
Precautions
Avoid if:
Severe liver impairment
Severe kidney impairment
Hypersensitivity to any ingredient
Not recommended during:
Pregnancy
Breastfeeding
Childhood due to insufficient safety data
Possible side effects:
Dry mouth
Nausea
Drowsiness
Allergic reactions
Use under healthcare supervision.
Disclaimer
This product should be used only according to healthcare professional guidance and local prescribing regulations.
